Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)?

S. Mokaddem Mohsen (Tunis, Tunisia)

Source: International Congress 2017 – Lung function testing in different patient categories
Session: Lung function testing in different patient categories
Session type: Thematic Poster
Number: 2477
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Mokaddem Mohsen (Tunis, Tunisia). Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)?. 2477

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Can fractional exhaled nitric oxide be useful to differentiate asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) from COPD-only
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Differential assessment of airway inflammation in chronic obstructive pulmonary disease (COPD) by measurements of exhaled nitric oxide (NO) derived from peripheral vs. central airways
Source: Eur Respir J 2003; 22: Suppl. 45, 279s
Year: 2003

Using fractional exhaled nitric oxide level to differentiate asthma–COPD overlap syndrome from COPD
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018

Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function
Source: Eur Respir J 2001; 17: 934-938
Year: 2001



Alveolar but not airway fractional exhaled nitric oxide concentration (FENO) is decreased in obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 467s
Year: 2003

Exhaled nitric oxide in respiratory diseases other than asthma
Source: Eur Respir Monogr 2010; 49: 45-55
Year: 2010


Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019

Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Characterization of airway inflammation in patients with asthma COPD overlap syndrome using FeNO levels
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Nitric oxide and oxygen inhalation during exercise in patients with chronic obstructive lung disease (COPD) and secondary pulmonary hypertension (PH)
Source: Eur Respir J 2001; 18: Suppl. 33, 83s
Year: 2001

The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO)
Source: Eur Respir J 2004; 24: Suppl. 48, 409s
Year: 2004

Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA)
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020


Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Concentration of exhaled nitric oxide (FENO) in patients with obstructive sleep apnea
Source: Eur Respir J 2004; 24: Suppl. 48, 118s
Year: 2004

Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma?
Source: Eur Respir J 2002; 20: Suppl. 38, 196s
Year: 2002

Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009


Exhaled nitric oxide in obstructive sleep apnea (OSA) patients: short and long term response to automatic positive airway pressure (APAP) therapy
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008


Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Exercise training and exhaled nitric oxide (eNO) in COPD patients of different severity
Source: Eur Respir J 2001; 18: Suppl. 33, 222s
Year: 2001